{
    "title": "Sepsis associated with low vitamin D",
    "slug": "sepsis-associated-with-low-vitamin-d",
    "aliases": [
        "/Sepsis+associated+with+low+vitamin+D+-+April+2012",
        "/2644"
    ],
    "tiki_page_id": 2644,
    "date": "2012-04-26",
    "categories": [
        "Trauma and surgery"
    ],
    "tags": [
        "RSV",
        "Trauma and surgery",
        "bacteria",
        "blood levels",
        "bone",
        "breathing",
        "child",
        "childhood obesity",
        "childhood pneumonia",
        "childhood respiratory",
        "childhood viruses",
        "clostridium difficile",
        "cystic fibrosis",
        "diabetes",
        "diabetes and vitamin d receptor",
        "dosage",
        "falls fractures",
        "genetics",
        "gut",
        "health risk",
        "hypertension",
        "immunity",
        "influenza",
        "life span",
        "metabolic",
        "mortality",
        "obesity",
        "obesity and vitamin d receptor",
        "pneumonia",
        "respiratory",
        "sepsis",
        "trauma surgery",
        "ultraviolet light",
        "virus",
        "virus and obesity",
        "viruses and vitamin d receptor",
        "vitamin d",
        "vitamin d and viruses",
        "vitamin d blood test",
        "vitamin d receptor"
    ]
}


### There are two items on this page

## See also VitaminDWiki

* [ICU surgical patients with low vitamin D stayed longer and had more sepsis – Dec 2011](/posts/icu-surgical-patients-with-low-vitamin-d-stayed-longer-and-had-more-sepsis)

* [Vitamin D might reduce sepsis](/posts/vitamin-d-might-reduce-sepsis)

* [ **<span style="color:#00F;">MRSA </span>** inpatient cost 2X higher if less than 20 ng vitamin D – June 2011](/tags/span-stylecolor00fmrsa-span-inpatient-cost-2x-higher-if-less-than-20-ng-vitamin-d-june-2011.html)

* [Staph infection reduced 50 percent when have more than 30 ng of vitamin D – Aug 2011](/posts/staph-infection-reduced-50-percent-when-have-more-than-30-ng-of-vitamin-d)

* [Critically ill patients with low vitamin D were 13X more likely to have a lot of mitrocondrial DNA in blood – Sept 2014](/posts/critically-ill-patients-with-low-vitamin-d-were-13x-more-likely-to-have-a-lot-of-al-dna-in-blood)

* [Septic patients vitamin D so low that small changes did not matter – June 2011](/posts/septic-patients-vitamin-d-so-low-that-small-changes-did-not-matter)

* [Sepsis bacteria can be killed by blue as well as UV light – Jan 2013](/posts/sepsis-bacteria-can-be-killed-by-blue-as-well-as-uv-light)

* [More sepsis deaths when active vitamin D (Calcitrol) was low – May 2013](/posts/more-sepsis-deaths-when-active-vitamin-d-calcitrol-was-low)

* [More sepsis deaths in those entering hospital with low vitamin D – Jan 2014](/posts/more-sepsis-deaths-in-those-entering-hospital-with-low-vitamin-d)

* [Google Search for SEPSIS at VitaminDWiki](http://www.google.com/custom?hl=en&client=google-coop-np&cof=FORID:13%3BAH:left%3BCX:Search%2520Vitamin%2520D%2520Wiki%3BL:http://www.google.com/intl/en/images/logos/custom_search_logo_sm.gif%3BLH:30%3BLP:1%3BKMBOC:%23336699%3B&cx=001215644404345293668:3di8vufs_m4&adkw=AELymgVbrpTB40R556_4rfJZSbw8-TBAytnIE4ofDyo2GQpQMI-4dJgf5YD-dLXaJ2asop6o7nT8CZzFBWo-OW08zk4PVZb4omjUMLKzgkLRWlEnZpXBIag&boostcse=0&ei=ZbMqTvaEHYHliALbhdGwAg&q=sepsis&start=20&sa=N)   **<span style="color:#00F;">128 items as of Feb 2014</span>** 

---

## Vitamin D in sepsis: from basic science to clinical impact

Jordan A Kempker 1 jkempke@emory.edu, Vin Tangpricha 2, Thomas R Ziegler 3 and Greg S Martin 1

Critical Care 2012, 16:316 doi:10.1186/cc11252; Published: 19 July 2012

The growing basic and clinical investigations into the extraskeletal effects of vitamin D have revealed roles in the functioning of the immune system, generating interesting questions about this nutrient's connections to sepsis. 

This article briefly reviews the current science of the function of vitamin D in the immune system as well as the emerging clinical literature regarding its associations with respiratory infections, sepsis, and critical illness. 

Finally, we offer views on the potential future directions for research in the field by outlining potential relevant scenarios and outcomes.

---

 **Update March 2016 <i class="fas fa-file-pdf" style="margin-right: 0.3em;"></i><a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vitamin-d-in-sepsis-2012.pdf">Download the final PDF from VitaminDWiki</a>** 

### rough copy from [dermatoendocrinology](http://www.landesbioscience.com/journals/dermatoendocrinology/article/19859/?show_full_text=true)

### Figure 1

<img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/sepsis-fig1.jpg" alt="image">

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">

<HTML>

<HEAD>

<META HTTP-EQUIV="CONTENT-TYPE" CONTENT="text/html; charset=windows-1252">

<TITLE></TITLE>

<META NAME="GENERATOR" CONTENT="OpenOffice.org 3.3  (Win32)">

<META NAME="AUTHOR" CONTENT="Henry Lahore">

<META NAME="CREATED" CONTENT="20120426;7230928">

<META NAME="CHANGEDBY" CONTENT="Henry Lahore">

<META NAME="CHANGED" CONTENT="20120426;7264400">

<STYLE TYPE="text/css">

<!--

@page { margin: 0.79in }

P { margin-bottom: 0.08in }

H2 { margin-bottom: 0.08in }

H2.cjk { font-family: "SimSun" }

H2.ctl { font-family: "Mangal" }

H5 { margin-bottom: 0.08in }

H5.cjk { font-family: "SimSun" }

H5.ctl { font-family: "Mangal" }

H4 { margin-bottom: 0.08in }

H4.cjk { font-family: "SimSun" }

H4.ctl { font-family: "Mangal" }

H3 { margin-bottom: 0.08in }

H3.cjk { font-family: "SimSun" }

H3.ctl { font-family: "Mangal" }

TD P { margin-bottom: 0in }

A:link { so-language: zxx }

-->

</STYLE>

</HEAD>

<BODY LANG="en-US" DIR="LTR">

<H2 CLASS="western" STYLE="font-style: normal; font-weight: normal"><A NAME="article_title"></A>

<FONT COLOR="#654d3e"><FONT FACE="Helvetica Neue, Arial, Helvetica, sans-serif">Vitamin

D and sepsis: An emerging relationship</FONT></FONT></H2>

<H3 CLASS="western" STYLE="margin-top: 0in; border: none; padding: 0in; line-height: 130%; widows: 2; orphans: 2">

<SPAN ID="Frame1" DIR="LTR" STYLE="float: left; width: 5.31in; height: 0.02in; border: none; padding: 0in; background: #ffffff">

<P STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2"><A NAME="issue_url"></A>

<A HREF="http://www.landesbioscience.com/journals/dermatoendocrinology/toc/volume/4/issue/2/"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><SPAN STYLE="font-style: normal"><SPAN STYLE="font-weight: normal">Volume

4, Issue 2</SPAN></SPAN></FONT></FONT></SPAN></FONT></A><FONT COLOR="#222222"><FONT FACE="Helvetica Neue, Arial, Helvetica, sans-serif"><FONT SIZE=2 STYLE="font-size: 9pt"><SPAN STYLE="font-style: normal"><SPAN STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;April/May

2012<BR></SPAN></SPAN></FONT></FONT></FONT><FONT COLOR="#222222"><FONT FACE="Helvetica Neue, Arial, Helvetica, sans-serif"><FONT SIZE=2 STYLE="font-size: 9pt"><SPAN STYLE="font-style: normal"><B>Keywords</B></SPAN></FONT></FONT></FONT><FONT COLOR="#222222"><FONT FACE="Helvetica Neue, Arial, Helvetica, sans-serif"><FONT SIZE=2 STYLE="font-size: 9pt"><SPAN STYLE="font-style: normal"><SPAN STYLE="font-weight: normal">:

critical care medicine, infection, nutrition, sepsis, severe sepsis,

Vitamin D</SPAN></SPAN></FONT></FONT></FONT></P>

<H5 CLASS="western" STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2"><A NAME="author_commalist"></A>

<FONT COLOR="#111111"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Authors</B>:

Jordan A. Kempker, Jenny E. Han, Vin Tangpricha, Thomas R. Ziegler

and Greg S. Martin</FONT></FONT></FONT></H5>

<P STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222">&nbsp;</FONT></P>

<P STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2"><A NAME="abstract"></A>

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Vitamin

D insufficiency and sepsis are both highly prevalent worldwide

problems and this article reviews the emerging science that is

defining the intersections of these conditions. The importance of

vitamin D&rsquo;s role in skeletal health has long been understood

but recent evidence is beginning to highlight its role in the

functioning of other physiologic systems of the body. Basic science

data reveal its integral role in local immune responses to pathogens

and the systemic inflammatory pathways of sepsis. Furthermore,

clinical scientists have found associations with respiratory

infections, critical illness and sepsis but the causal relationship

and its clinical impact have yet to be clearly defined. The article

ends with speculations on the connections between racial disparities

and seasonal differences in sepsis and vitamin D insufficiency.</FONT></FONT></FONT></P>

</SPAN>

<SPAN ID="links_box" DIR="LTR" STYLE="float: left; width: 2.4in; height: 0.02in; border: none; padding: 0in; background: #ffffff">

<P STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><SPAN STYLE="font-style: normal"><SPAN STYLE="font-weight: normal"><SPAN STYLE="background: #f2faf8"><BR><BR></SPAN></SPAN></SPAN></FONT></FONT></FONT><BR>

</P>

</SPAN><BR><BR>

</H3>

<DIV ID="full_text" DIR="LTR">

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<BR><BR>

</H4>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<BR><BR>

</H4>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<BR><BR>

</H4>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<BR><BR>

</H4>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<BR><BR>

</H4>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<BR><BR>

</H4>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<BR><BR>

</H4>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<BR><BR>

</H4>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<BR><BR>

</H4>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<BR><BR>

</H4>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<FONT COLOR="#654d3e"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Introduction</B></FONT></FONT></FONT></H4>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">The

importance of vitamin D on bone health and calcium homeostasis has

long been understood. However, scientists are beginning to uncover

that this steroid hormone has important roles in the optimal

functioning of many organ systems. Vitamin D receptors and

25-hydroxyvitamin D-1&alpha;-hydroxylase (1&alpha;-OHase) have been

discovered in many extraskeletal tissues and the vitamin D response

element (VDRE) found in over 900 genes.1&nbsp;Furthermore, recent

epidemiologic and clinical trials have suggested that optimal

vitamin D status may be protective against several chronic

illnesses, including risk of systemic infection, cardiovascular

disease, lung disease and diabetes.2-6</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Highlighting

the importance of the recent discoveries of vitamin D&rsquo;s

pleiotropic effects on human health, numerous recent publications

have explored the definition of vitamin D deficiency and its

prevalence. In 2011, the Institute of Medicine issued a publication

establishing a serum 25-hydroxyvitamin D (25(OH)D) concentration of

20ng/mL as an optimal concentration for skeletal health for the US

population.7&nbsp;In the same year, the Endocrine Society

recommended a serum 25(OH)D concentration of at least 30 ng/mL for

optimal health benefits.3Using the Endocrine Society&rsquo;s target,

40&ndash;100% of US elderly individuals in the community are vitamin

D insufficient along with an estimated 1 billion people in the

world.8</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">The

developing science around vitamin D has begun to reveal potential

links between its deficiency and sepsis. The connections between

these conditions are still in the early phases of discovery. This

review will discuss the various basic and clinical research studies

that are examining this relationship, covering the data from

experimental models of infection and sepsis to the clinical data on

respiratory infections and critical illness.</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<FONT COLOR="#654d3e"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Vitamin

D and the Immune System</B></FONT></FONT></FONT></H4>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">A

vital role for vitamin D in the human system was initially indicated

by the discovery of vitamin D receptors (VDR) in nearly all types of

immune cells, including activated CD4+ and CD8+ T cells, B cells,

neutrophils, macrophages and dendritic cells.9&nbsp;These cells span

the body&rsquo;s innate and adaptive immune responses to pathogens.

The relationship being uncovered by scientists is complex, yet the

underlying theme seems to be one of modulating the adaptive immune

response while promoting innate immunity.10&nbsp;In regards to

adaptive immunity, vitamin D affects the proliferation and

differentiation of B and T cells and modulates immunoglobulin

production10&nbsp;with one study showing suppression of antibody

response to pneumococcal antigens in mice.11&nbsp;While these

effects may have important roles in autoimmunity, it is not yet

clear whether they will have a beneficial role in infection or

sepsis. In contrast, vitamin D&rsquo;s promotional effects on innate

immunity have been more clearly elucidated at this time and will be

the focus in this review.</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">The

innate immune system acts to rapidly identify invading organisms and

respond with humoral and cellular defense mechanisms to contain,

neutralize and remove offending pathogens. These pathogens are

identified by highly conserved pathogen-associated molecular

patterns (PAMP) that bind to pathogen-recognition receptors (PRR) on

immune cells. The cells that participate in these innate immune

responses include neutrophils and monocytes as well as epithelial

cells that not only provide barrier function but also have

anti-pathogen activity. As discussed below, vitamin D is a key

component in several of the pathways of this system.9,12</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<FONT COLOR="#654d3e"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Vitamin

D and the Sepsis Cascade</B></FONT></FONT></FONT></H4>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Monocytes

play important roles in the innate immune system as antigen

presenting cells as well as in phagocytosis. Human monocytes

recognize some PAMPs by a family of transmembrane molecules, the

Toll-Like Receptors (TLRs). TLR4 specifically recognizes and binds

to lipopolysaccharide (LPS), a substance produced by gram-negative

bacteria and a potent stimulator of the sepsis inflammatory cascade.

Sadeghi et al. demonstrated that human monocytes stimulated with LPS

and treated with 1,25-dihydroxyvitamin D (1,25(OH)2D), showed

dose-dependent decreases in TLR2 and TLR4 synthesis, with an

increase in CD14, a TLR co-stimulatory molecule.13&nbsp;They further

found that 1,25(OH)2D decreased TNF-&alpha; and tissue factor, both

end products of LPS activation and important inflammatory molecules

in sepsis.13&nbsp;These effects were reversed with the introduction

of a VDR antagonist, reinforcing a key role of vitamin D in this

signaling mechanism.13</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Further

studies have revealed a role for vitamin D in the endothelial

response to LPS. In sepsis, LPS activates endothelial cells to

produce transcription factor NF-&kappa;B, the pro-inflammatory

cytokines IL-6 and IL-8, and the chemokine, RANTES. In a study by

Equils et al., human endothelial cells treated with 1,25(OH)2D then

stimulated with LPS, showed significant inhibition of these

molecules when compared with cells only exposed to LPS.14&nbsp;These

findings may suggest that vitamin D acts to modulate the

pro-inflammatory endothelial response to LPS.</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Over

the past two decades, these intriguing vitamin D-dependent cellular

responses to LPS have also been studied in rat and mouse models of

sepsis. Horiuchi et al. exposed mice simultaneously to

intraperitoneal LPS and oral 1,25(OH)2D. Compared with controls,

mice that received vitamin D had less expression of the inflammatory

molecule, iTXB2, and a decrease in mortality.15&nbsp;In 2001,

Asakura et al. demonstrated that compared with low-molecular weight

heparin, treatment with oral 1,25(OH)2D had equal or improved

effects on hemostatic parameters and markers of organ dysfunction in

rats infused with LPS.16&nbsp;In 2007, Moller et al. performed

placebo controlled trials of treatment with 1,25(OH)2D in three

different rat models of sepsis showing varied results.17&nbsp;While

the different models of sepsis and vitamin D treatments in these

experiments make them difficult to compare, when combined with the

in vitro data they suggest that vitamin D has important modulatory

effects on the innate immune response to LPS-induced sepsis.</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">While

LPS is an important molecule in gram-negative sepsis, vitamin D may

also have a role in the sepsis cascade induced by fungal organisms.

A study by Khoo et al. treated peripheral blood mononuclear cells

(PBMC) with 1,25(OH)2D and exposed them to&nbsp;<I>C. albicans</I>.

The PBMCs demonstrated significant dose-dependent decreases in

production of pro-inflammatory cytokines with a decrease in

expression of the PRRs that recognize&nbsp;<I>C. albicans</I>.18</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<FONT COLOR="#654d3e"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Vitamin

D and Local Immune Defense</B></FONT></FONT></FONT></H4>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Vitamin

D&rsquo;s effects on the innate immune system encompass not only the

modulation of the systemic inflammatory response but also the local

control of pathogens. In vitro studies have shown that 50,000 -

90,000 IU/ml of vitamin D3&nbsp;inhibited growth or killed strains

of<I>Staphylococcus aureus, Streptococcus pyogenes, Klebsiella

pneumoniae, and Escherichia coli</I>.19&nbsp;Another study of

tracheobronchial epithelial cells infected with respiratory

sincytial virus showed decreases in inflammatory proteins without

increases in viral replication when treated with 1,25(OH)2D.20&nbsp;In

a model of bovine mastitis, Nelson et al. showed that infiltrating

monocytes from infected mammary tissue increased gene expression of

VDR and 1&alpha;-OHase.21&nbsp;This lends support to a vitamin

D-dependent response of the innate immune system that is triggered

by local infection.</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Another

important component of the innate immune response is the

antimicrobial peptides (AMP). These peptides initiate bacterial

killing by increasing bacterial cell membrane permeability once

inside a phagosome.12&nbsp;Studies have revealed vitamin D-dependent

steps in this process, demonstrating that the binding of bacterial

ligands to monocyte PRRs induces gene expression of the VDR and

1&alpha;-OHase genes.12&nbsp;In an autocrine fashion, 1&alpha;-OHase

activates 25(OH)D which binds to VDRs and then vitamin D response

elements (VDRE) to induce genes for the AMPs, &beta; defensin 4A and

hCAP18.12&nbsp;The latter molecule is then cleaved to its active

form LL-37.</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">LL-37

in particular has been extensively studied in its role in the

vitamin D-dependent pathways of the innate immune system. It is

produced by phagocytic leukocytes, mucosal epithelium and

keratinocytes, and is present in mucosal secretions and

plasma.22&nbsp;LL-37 has shown in vitro microbicidal activity

against important human pathogens including&nbsp;<I>Pseudomonas

aeruginosa, Salmonella typhimurium, Escherichia coli, Listeria

monocytogenes, Staphylococcus epidermidis, Staphylococcus aureus,

and vancomycin-resistant entero-cocci</I>.23&nbsp;In addition to

direct microbicidal activity, it has demonstrated disruption

of&nbsp;<I>Pseudomonas aeruginosa</I>&nbsp;biofilms, promotion of

phagocytosis and reactive oxygen species, and chemotaxis of other

immune cells to sites of infection.22&nbsp;In one study human

bronchial epithelial cells incubated with 1,25(OH)2D showed

increased production of LL-37 and reduced growth of airway

pathogens,&nbsp;<I>Bordetella bronchioseptica</I>&nbsp;and<I>Pseudomonas

aeruginosa</I>.24&nbsp;In another study of human bladder cells

challenged with&nbsp;<I>Escherichia coli</I>, oral vitamin D

pretreatment of subjects increased production of LL-37 and

bactericidal activity.25&nbsp;This effect was neutralized with

anti-LL-37 antibodies, highlighting LL-37 as a critical

antibacterial component of the vitamin D mediated immune

response.25&nbsp;LL-37 also appears to be linked to vitamin D status

in humans as a study by Jeng et al. showed a positive correlation

between plasma concentrations of LL-37 and 25(OH)D among patients

admitted to the ICU.26</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<FONT COLOR="#654d3e"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Clinical

Research on Vitamin D and Infection</B></FONT></FONT></FONT></H4>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Complementing

the basic science research of vitamin D&rsquo;s effects on the

innate immune system, clinical trials have examined its role in the

prevention and control of human infection. The studies have

predominantly studied vitamin D&rsquo;s role in respiratory

infections, the most common source of sepsis in the United

States27&nbsp;and the results have been mixed.</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">One

of the early observational studies that pointed toward a connection

between vitamin D and respiratory infections was a secondary

analysis of over 18,000 individuals of the US. National Health and

Nutrition Examination Survey (NHANES) III. In this study, Ginde et

al. found an inverse relationship between serum 25(OH)D

concentrations and the incidence of upper respiratory infections

(URI).28&nbsp;Vitamin D has since been studied in several clinical

trials to characterize its role in respiratory infections. In 2010,

Sabetta et al. conducted a prospective cohort study showing that

serum 25(OH)D concentrations of 38 ng/mL or greater were associated

with a 2-fold decrease in the number of upper respiratory

infections.29&nbsp;In contrast, Laaksi et al.&rsquo;s randomized

trial of vitamin D supplementation (400 IU daily of vitamin D3) did

not show a significant difference in the days absent from work due

to URI, although only about 30% of the intervention group achieved a

25(OH)D concentration &gt; 32 ng/mL30. Also of note, this study did

show a significant increase in the number of men remaining healthy

throughout the 6-mo study period.30&nbsp;Another randomized study by

Li-Ng et al. revealed that winter month oral vitamin D

supplementation (2000 IU daily of vitamin D3) did not reduce the

incidence, duration or severity of URIs among ambulatory adults.31</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">In

addition to these studies on URIs, there have been a number of

studies examining the relationship between vitamin D and acute lower

respiratory infections (ALRI) in infants and children. Three

case-control studies of newborns and children admitted with ALRI

showed an association between low vitamin D status and risk of

ALRI.32-34&nbsp;In contrast, two other case-control studies did not

reveal an association between vitamin D status and hospitalization

for ALRI in children, although one of them showed that it was

associated with admission to the ICU.35,36&nbsp;In an intervention

trial, Manaseki-Holland et al. showed that a single oral dose of

100,000 IU of vitamin D in children admitted for ALRI reduced rates

of recurrence in the subsequent three months, although it did not

shorten the duration of the index infection.37Urashima et al.

conducted a randomized trial of vitamin D supplementation (1200 IU

daily of vitamin D3) in school aged children during the winter and

found that supplementation significantly decreased the incidence of

influenza A infection, especially among children with predisposing

respiratory conditions.38</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">The

varied mixed of these studies may be methodological with the

different study designs, vitamin D treatments, outcome measures and

sample sizes. Rather than nullify the findings from the basic

sciences, they help direct future research in this area by

indicating that vitamin D&rsquo;s effects on infection will likely

be small and need large samples sizes and supplementation needs to

be adequate and sustained. In translating this research to sepsis it

is important to note that most of the above studies do not focus on

specific infective pathogens. While respiratory infections are the

most common cause of sepsis in the US, gram-positive bacteria are

the most common pathogens, followed by gram-negative bacteria with a

rise in fungi.39&nbsp;However, the clinical literature on vitamin D

and these organisms is sparse. A case-control study of the NHANES,

found an association between low vitamin D and increased nasal

colonization with MRSA.40&nbsp;Also a cross-sectional study of

veterans with clostridium difficile and staphylococcus aureus

infections, showed more hospitalizations and a 4-fold increase in

hospital length of stay among those with serum 25(OH)D &lt; 20

ng/mL.41&nbsp;Despite the limitations of the research on vitamin D

and infection, clinical science is still moving forward in exploring

its connections with sepsis.</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<FONT COLOR="#654d3e"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Vitamin

D in the Critically Ill</B></FONT></FONT></FONT></H4>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">As

vitamin D&rsquo;s role in the immune system is beginning to be

pieced together through its local and systemic effects on immune

responses to pathogens, there has been an interest in its role in

critically ill patients. While this review will focus on the

prevalence of vitamin D insufficiency and its connections with

sepsis in the critically ill, it is important to note vitamin D&rsquo;s

other potential roles within this population, including patients

with severe hypocalcemia, increased bone turnover in prolonged

illness and a possible connection with insulin resistance.42-44</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Several

studies have revealed a high prevalence of vitamin D insufficiency

among the critically ill, although its association with outcomes has

been less clear. A single center prospective observational study

examined all ICU patients admitted in a spring-summer season and

found serum 25(OH)D concentrations &lt; 24 ng/mL in 79%.45&nbsp;Spring

admission, low albumin and high Simplified Acute Physiology II score

were all independently associated with low serum 25(OH)D

concentrations.45&nbsp;They did not find associations between

vitamin D, mortality or hospital-acquired infections in the overall

group or in the septic subgroup.45&nbsp;McKinney et al. conducted a

retrospective study of 136 veterans admitted to the ICU who had a

serum 25(OH)D drawn within a month before or after admission to the

ICU. Ninety-eight percent of the veterans had low serum 25(OH)D

concentrations.46&nbsp;The study also demonstrated a significantly

increased survival rate (69% vs. 44%) among those with serum 25(OH)D

concentrations greater than 20ng/mL.46&nbsp;A retrospective study by

Venkatram et al. revealed an association between mortality and

vitamin D deficiency (25(OH)D &lt; 20 ng/mL) in 437 patients at a

single center ICU.47</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Other

studies have provided more specific data on the relationship between

vitamin D and septic patients. Jeng et al. showed that vitamin D

insufficiency was present in 100% of critically ill patients with

sepsis, 92% of critically ill patients without sepsis and 66.5% in

healthy controls.26&nbsp;A prospective study of 66 surgical ICU

patients showed a non-significant trend toward an increased rate of

infections and sepsis among the vitamin D deficient (&lt; 20

ng/mL).48&nbsp;Braun et al. conducted two retrospective studies on

the same source population investigating this subject. One was a

retrospective analysis of 2,399 patients admitted to medical and

surgical ICUs with a 25(OH)D drawn within the year prior to

admission. The data showed a 1.3 and 1.7 fold increase in all-cause

mortality among vitamin D insufficient and deficient groups (&lt;

30ng/mL and &lt; 15ng/mL) respectively and a significant increase in

blood culture positivity.49&nbsp;The other analysis was of 1,325

patients with a 25(OH)D drawn 7 d before or after ICU admission and

revealed a significant association between vitamin D deficiency (&lt;

15ng/mL) and increased mortality at 30, 90 and 365 d.50&nbsp;The

vitamin D-mortality association in both analyses was not modified by

the presence of sepsis.49,50&nbsp;Highlighting the complexity of

confounding in critically ill and septic patients, a prospective

study by Cecchi et al. found a relationship between mortality and

vitamin D deficiency among 170 patients with severe sepsis and

septic shock that became insignificant after adjustment.51</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">A

pilot study by Ginde et al. more specifically looked at low vitamin

D and its effects on the severity of sepsis. The investigators

followed 81 patients suspected of having an infection in the

Emergency Department and examined their severity of illness in

comparison to vitamin D status. They found that patients with serum

25(OH)D concentrations less than 30ng/mL were more likely at

enrollment to have severe sepsis and SOFA (Sepsis-related Organ

Failure Assessment) scores &ge; 2 and more likely at 24 h to have

severe sepsis, SOFA scores &ge; 2, APACHE II (Acute Physiology and

Chronic Health Evaluation II) scores &ge; 25 and dysfunction of two

or more organ systems.52</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Overall,

the evidence suggests associations between vitamin D depletion and

critical illness-related outcomes with the link to sepsis less

clear. These relationships are likely confounded by many common risk

factors such as age, socio-economic status, obesity, and chronic

illness. In regards to the last risk factor, chronically ill and

debilitated individuals likely spend more time indoors with

consequent less sun exposure and more vitamin D deficiency. These

confounding associations make it difficult to prove causality in

critical-illness outcomes. In addition to these epidemiological

phenomena, sepsis therapy may also confound this relationship. One

study demonstrated this by showing that the hemodilutional effects

of fluid resuscitation can decrease serum 25(OH)D concentration by

35%.53&nbsp;These issues reveal the complexity of research in this

field and the important confounders that must be accounted for in

future studies.</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<FONT COLOR="#654d3e"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Vitamin

D and the Seasonal and Racial Variation in Sepsis</B></FONT></FONT></FONT></H4>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">While

no studies have directly examined the association between the

seasonal and geographic variations of serum 25(OH)D concentrations

and the incidence of sepsis, evidence suggests possible

parallels.54&nbsp;A study surveying the national hospital discharge

database from 1979 to 2003 in the USA, showed a significant seasonal

variation of sepsis and severe sepsis with the highest incidences in

the winter and the lowest in the fall, with a parallel variation in

the incidence of the most common cause of sepsis, respiratory

infections.55&nbsp;Furthermore, the Northeast USA showed the

greatest seasonal variation in sepsis incidence compared with the

Southern USA which showed the least variation.55&nbsp;These patterns

parallel the annual variations in serum 25(OH)D concentrations, with

peak concentrations in the fall and a nadir after the winter.56&nbsp;This

is in part explained by the elliptical orbit of the earth around the

sun, changing the solar zenith angle throughout the seasons, which

effects the amount of UV B radiation reaching the earth&rsquo;s

surface.57&nbsp;Interestingly, this seasonal variation of vitamin D

synthesizing radiation is less pronounced nearer the equator where

the seasonal variation of sepsis and respiratory infections may be

lower.57,58&nbsp;This speculation, however, oversimplifies the other

geophysical factors that affect vitamin D synthesis, including cloud

and ozone cover, altitude and surface reflectivity.57</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">There

are also human factors that effect vitamin D synthesis including sun

protective behaviors and skin pigmentation, the latter of which may

also point toward links between vitamin D and racial differences in

sepsis. Studies have shown that in the US, blacks are nearly twice

as likely to develop sepsis as whites,39&nbsp;develop more

infections59&nbsp;and have higher rates of organ dysfunction with

sepsis.60&nbsp;While vitamin D status was not included in these

studies, blacks tend to have lower serum 25(OH)D concentrations than

whites. In a recent review, Grant outlined cross-sectional data

showing serum 25(OH)D concentrations to be 16 ng/mL, 21 ng/mL and 26

ng/mL among blacks, Hispanics and whites in the US.61&nbsp;This

could be explained by the fact that increased skin pigmentation

leads to less production of vitamin D as melanin absorbs and

competes for UVB radiation.62&nbsp;With vitamin D&rsquo;s

pleiotropic effects on bodily health, it has been suggested that it

may be a contributing cause for racial disparities across many

diseases61&nbsp;and its effects on the immune system may provide a

connection with the higher rates of infection and sepsis in blacks.

As with the seasonal variation hypothesis, there are no studies that

directly examine this relationship, but the speculations warrant

further investigation.</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<FONT COLOR="#654d3e"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Conclusion</B></FONT></FONT></FONT></H4>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">The

multiple functions of vitamin D in the immune system&rsquo;s

response to infection suggest it may be an integral component in

combating sepsis. The basic science data point toward vitamin D&rsquo;s

role in the optimal functioning of the innate immune system, in part

by producing AMPs such as LL-37; while seeming to temper the

inflammatory cascade induced by LPS. The early clinical data on its

role in preventing and attenuating infections has suggested a link

but intervention trials have produced mixed results, requiring

larger randomized controlled trials to help define the relationship.

Furthermore, clinical data also point toward a role of vitamin D and

critical illness but a direct relationship with sepsis and its

severity and outcomes is yet to be determined by further research.

Some interesting parallel patterns between vitamin D and seasonal

and racial variations in sepsis are currently speculative but

interesting questions to be explored. In conclusion, the current

picture of vitamin D and sepsis is one of a research field early in

its course with many important links that provide fertile ground for

further investigation. Such investigation is warranted as vitamin D

is inexpensive and safe to administer and even incremental benefits

in the outcomes of sepsis may be enacted on a scale to produce a

significant public health impact (Fig. 1,&nbsp;Tables 1,&nbsp;2and&nbsp;3).</FONT></FONT></FONT></P>

<P ALIGN=CENTER STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2; text-decoration: none">

<BR>

</P>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><SPAN STYLE="background: #f2faf8"><B>Figure&nbsp;1.</B>&nbsp;Morbidity

and mortality vitamin D insufficiency and sepsis. Venn diagram

reflecting the links between vitamin D&rsquo;s roles in innate

immune function, clinical infections and sepsis in the critically

ill. The intersections represent the potential increased morbidity

and mortality resulting from vitamin D insufficient states

predisposing to and exacerbating sepsis.</SPAN></FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Table&nbsp;1.&nbsp;Basic

science studies of vitamin D and the innate immune response. Summary

of basic science data showing vitamin D&rsquo;s effects in cell and

animal models of infection and sepsis</B></FONT></FONT></FONT></P>

<TABLE CELLPADDING=2 CELLSPACING=2>

<COL WIDTH=0>

<COL WIDTH=0>

<COL WIDTH=0>

<COL WIDTH=0>

<THEAD>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Year</B></FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Author</B></FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Design</B></FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Results</B></FONT></FONT></P>

</TD>

</TR>

</THEAD>

<TBODY>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">1991</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Horiuchi

et al.15</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Mice

given intraperitoneal LPS and 1,25D</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Decrease

iTXB2&nbsp;and mortality</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2001</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Asakura

et al.16</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Rats

given LPS infusion with 1,25D or LMWH</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Equal

or improved hemostatic parameters and markers of organ

dysfunction</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2006</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Sadeghi

et al.13</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Human

monocytes given LPS and 1,25D</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Dose-dependent

decrease in TLR2, TLR4, TNF&alpha;, TF and increase in CD14</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2006</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Equils

et al.14</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Human

endothelial cells given LPS and 1,25D</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Inhibition

of IL-6, IL-8, RANTES and NF&kappa;B</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2007</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Moller

et al.17</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Rats

with Cecal Ligation given 1,25D</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Decreased

thrombocytopenia and total bilirubin rise</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD></TD>

<TD></TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Rats

given IV or intraperitoneal LPS and 1,25D</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Increased

creatinine</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2009</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Yim et

al.24</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Human

bronchial epithelial cells given 1,25D</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Increased

LL-37 and reduced growth of&nbsp;<I>P. aeuroginosa</I>&nbsp;and&nbsp;<I>B.

bronchioseptica</I></FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2010</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Nelson

et al.21</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Monocytes

from bovine mastitis model</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Increased

expression of monocyte VDR and 1&alpha;-OHlase</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2010</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Hertting

et al.25</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Human

bladder cells after 3 mo oral 25D in vivo with in vitro&nbsp;<I>E.

coli</I>&nbsp;challenge</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Increased

LL-37 and bactericidal activity</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2011</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Khoo et

al.18</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Human

PBMCs exposed to C. albicans and 1,25D in vitro</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Dose-dependent

decrease in TNF&alpha;, IL-6, IL-17, TLR2, TLR4 and mannose

receptors</FONT></FONT></P>

</TD>

</TR>

</TBODY>

</TABLE>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">1,25D,

1,25-dihydroxyvitamin D; 25D, 25-hydroxyvitamin D</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Table&nbsp;2.&nbsp;Clinical

studies of vitamin D and infections: Summary of observational and

experimental data on vitamin D&rsquo;s effects in infections</B></FONT></FONT></FONT></P>

<TABLE CELLPADDING=2 CELLSPACING=2>

<COL WIDTH=0>

<COL WIDTH=0>

<COL WIDTH=0>

<COL WIDTH=0>

<COL WIDTH=0>

<THEAD>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Year</B></FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Author</B></FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Design</B></FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Sample

Size</B></FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Results</B></FONT></FONT></P>

</TD>

</TR>

</THEAD>

<TBODY>

<TR VALIGN=TOP>

<TD COLSPAN=2>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Observational

Studies</B></FONT></FONT></P>

</TD>

<TD></TD>

<TD></TD>

<TD></TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2009</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Ginde

et al.28</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Case-control

study of NHANES III</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n =

18,883</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Inverse

relationship between 25D levels and incidence of URI.</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2009</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Wayse

et al.32</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Case-control

study of children &lt; 5 y old in India</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 150</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">25D &gt;

9 ng/mL associated with lower risk of ALRI</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2009</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Karatekin

et al.33</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Case-control

study of infants admitted to NICU for ALRI in Turkey</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 40</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Admission

for ALRI associated with lower 25D levels</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2009</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Roth et

al.35</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Case-control

study of infants 1&ndash;25 mo old admitted for ALRI in Alberta</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 129</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">No

difference in 25D levels among children admitted for ALRI</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2009</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">McNally

et al.36</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Case-control

study of infants 1&ndash;11 mo old admitted for ALRI in

Saskatchewan</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 197</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">There

was no difference in 25D levels among children admitted for ALRI</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2010</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Youssef

et al.41</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Cross-sectional

analysis of veterans with&nbsp;<I>MSSA</I>&nbsp;and&nbsp;<I>C.

difficile</I>&nbsp;infections and 25D level within 3 mo</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 52</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">25D &lt;

20ng/mL associated with increased costs and hospitalization days</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2010</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Matheson

et al.40</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Case-control

study of NHANES 201&ndash;2004</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n =

14,639</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">25D &lt;

20 ng/mL associated with increased risk of nasal carriage of

MRSA</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2010</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Sabetta

et al.29</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Prospective

cohort of healthy US adults</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 198</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">25D &gt;

38 ng/mL associated with 2 fold decrease in URI</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2010</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Roth et

al.34</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Case-control

study of infants 1&ndash;18 mo of age admitted for ALRI in

Bangladesh</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 50</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Admission

for ALRI was associated with lower 25D levels</FONT></FONT></P>

</TD>

</TR>

<TR>

<TD COLSPAN=5 VALIGN=TOP>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Experimental

Studies of Patients Given Oral Vitamin D</B></FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2009</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Li-Ng

et al.31</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">RCT of

New York adult volunteers given 2000 IU/day for 12 weeks</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 162</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">No

difference in incidence of URIs</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2010</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Laaksi

et al.30</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">RCT of

Finnish men in military training randomized to 6 mo of 400

IU/day</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 164</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Increased

number of men remaining healthy during study but no difference

in days missed from duty due to respiratory infections.</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2010</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Manaseki-Holland

et al.37</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">RCT of

children 1&ndash;36 mo old admitted to hospital in Kabul for

ALRI given 100,000 IU once</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 453</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Reduced

recurrence ALRI at 90 d but no difference duration of index

ALRI.</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2010</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Urashima

et al.38</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">RCT of

Japanese schoolchildren given 1200 IU/day D over 4 winter months</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 334</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Reduced

incidence of influenza A</FONT></FONT></P>

</TD>

</TR>

</TBODY>

</TABLE>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">25D,

25-hydroxyvitamin D; MRSA, methicillin-resistant Staphylococcus

aureus; MSSA, methicillin-sensitive Staphylococcus aureus; RCT,

randomized controlled trial</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; font-style: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Table&nbsp;3.&nbsp;Clinical

studies of vitamin D and sepsis: Summary of observational data on

the links between vitamin D and sepsis among the critically ill</B></FONT></FONT></FONT></P>

<TABLE CELLPADDING=2 CELLSPACING=2>

<COL WIDTH=0>

<COL WIDTH=0>

<COL WIDTH=0>

<COL WIDTH=0>

<COL WIDTH=0>

<THEAD>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Year</B></FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Authors</B></FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Design</B></FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Sample

Size</B></FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Results</B></FONT></FONT></P>

</TD>

</TR>

</THEAD>

<TBODY>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2009</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Jeng et

al.26</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Case-control

study of patients admitted with or without sepsis compared with

non-hospitalized controls in Atlanta</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 70</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Prevalences

of 25D &lt; 30ng/mL: 100% in sepsis, 92% and 66.5% in controls</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2010</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Lucidarme

et al.45</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Prospective

cohort in ICU in France</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 134</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Seventy-nine

percent with 25D &lt; 24 ng/mL, associated with high SAPS II

score but not nosocomial infections or mortality</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2011</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Cecchi

et al.51</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Prospective

cohort of patients with severe sepsis and septic shock compared

with trauma patients in a general ICU in Florence, Italy</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 170</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Median

25D concentration was lower in septic group and associated with

increased mortality only in unadjusted analysis</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2011</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">McKinney

et al.46</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Retrospective

cohort of veterans admitted to a Tennessee ICU with a 25D level

drawn within the month</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 136</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Sixty

percent with 25D &lt; 30ng/mL, which was associated to mortality</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2011</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Flynn

et al.48</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Prospective

observational cohort of surgical ICU patients in Detroit, 50% of

which received vitamin D supplements</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 66</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Seventy-four

percent &lt; 20 ng/mL, which was associated with non-significant

trends in increased infection and sepsis</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2011</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Vankatram

et al.47</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Retrospective

cohort of patients in a New York medical ICU with 25D drawn

within 24 h of admission</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 437</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">25D &lt;

20 ng/mL was associated with hospital mortality</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2011</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Braun

et al.49</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Retrospective

cohort of patents admitted to 2 Boston ICUs who had a 25D level

7&ndash;365 d before admission</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n =

2,399</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">25D &lt;

15 ng/mL associated with increased mortality and blood culture

positivity. Mortality association not modified by presence of

sepsis</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2011</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Ginde

et al.52</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Prospective

cohort pilot of adults admitted from Emergency Department with

suspected infection</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n = 81</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Seventy-nine

percent with 25D &lt; 30 ng/mL and associated with increased

severity sepsis at admission and 24 h</FONT></FONT></P>

</TD>

</TR>

<TR VALIGN=TOP>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2012</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Braun

et al.50</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">Retrospective

cohort of patents admitted to 2 Boston ICUs who had a 25D level

7 d before or after ICU admission</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">n =

1,325</FONT></FONT></P>

</TD>

<TD>

<P ALIGN=LEFT STYLE="border: none; padding: 0in; font-weight: normal">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">25D &lt;

15 ng/ml associated with increased mortality which was not

modified by the presence of sepsis</FONT></FONT></P>

</TD>

</TR>

</TBODY>

</TABLE>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">25D,

25-hydroxyvitamin D</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<FONT COLOR="#654d3e"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Disclosure

of Potential Conflicts of Interest</B></FONT></FONT></FONT></H4>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">The

authors have no conflicts of interest to declare.</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<FONT COLOR="#654d3e"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>Acknowledgments</B></FONT></FONT></FONT></H4>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<P ALIGN=JUSTIFY STYLE="border: none; padding: 0in; font-style: normal; font-weight: normal; line-height: 0.19in; widows: 2; orphans: 2">

<FONT COLOR="#222222"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">This

work is supported in part by National Institutes of Health grants

T32 AA013528 (J.A.K. and J.E.H.), K23 AR054334 (V.T.), K24 RR023356

(T.R.Z.), R21 HL110044 (G.S.M. and T.R.Z.), U54 RR-024380, P50

AA-013757P50, AA013757 (G.S.M.) and the Atlanta Clinical and

Translational Science Institute (UL1 RR025008).</FONT></FONT></FONT></P>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<H4 CLASS="western" ALIGN=JUSTIFY STYLE="margin-top: 0in; border: none; padding: 0in; font-style: normal; line-height: 125%; widows: 2; orphans: 2">

<FONT COLOR="#654d3e"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt"><B>References</B></FONT></FONT></FONT></H4>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R1" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">1.

Wang&nbsp;TT, Tavera-Mendoza&nbsp;LE, Laperriere&nbsp;D, Libby&nbsp;E,

MacLeod&nbsp;NB, Nagai&nbsp;Y, et al.&nbsp;Large-scale in silico

and microarray-based identification of direct 1,25-dihydroxyvitamin

D3 target genes. Mol Endocrinol&nbsp;2005; 19:2685-95;

PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/16002434" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">16002434</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1210/me.2005-0106" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1210/me.2005-0106</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R2" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">2.

Autier&nbsp;P, Gandini&nbsp;S.&nbsp;Vitamin D supplementation and

total mortality: a meta-analysis of randomized controlled trials.

Arch Intern Med&nbsp;2007; 167:1730-7; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/17846391" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">17846391</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1001/archinte.167.16.1730" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1001/archinte.167.16.1730</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R3" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">3.

Holick&nbsp;MF, Binkley&nbsp;NC, Bischoff-Ferrari&nbsp;HA,

Gordon&nbsp;CM, Hanley&nbsp;DA, Heaney&nbsp;RP, et al.&nbsp;Evaluation,

treatment, and prevention of vitamin D deficiency: an Endocrine

Society clinical practice guideline. J Clin Endocrinol Metab&nbsp;2011;

96:1911-30; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21646368" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21646368</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1210/jc.2011-0385" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1210/jc.2011-0385</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R4" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">4.

Yamshchikov&nbsp;AV, Desai&nbsp;NS, Blumberg&nbsp;HM, Ziegler&nbsp;TR,

Tangpricha&nbsp;V.&nbsp;Vitamin D for treatment and prevention of

infectious diseases: a systematic review of randomized controlled

trials. Endocr Pract&nbsp;2009; 15:438-49; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/19491064" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">19491064</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.4158/EP09101.ORR" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.4158/EP09101.ORR</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R5" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">5.

Sokol&nbsp;SI, Tsang&nbsp;P, Aggarwal&nbsp;V, Melamed&nbsp;ML,

Srinivas&nbsp;VS.&nbsp;Vitamin D status and risk of cardiovascular

events: lessons learned via systematic review and meta-analysis.

Cardiol Rev&nbsp;2011; 19:192-201; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21646873" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21646873</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1097/CRD.0b013e31821da9a5" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1097/CRD.0b013e31821da9a5</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R6" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">6. Zhao&nbsp;G,

Ford&nbsp;ES, Li&nbsp;C, Croft&nbsp;JB.&nbsp;Serum

25-hydroxyvitamin D levels and all-cause and cardiovascular disease

mortality among US adults with hypertension: the NHANES linked

mortality study. J Hypertens&nbsp;2012; 30:284-9; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/22179077" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">22179077</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1097/HJH.0b013e32834e1f0a" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1097/HJH.0b013e32834e1f0a</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R7" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">7. Ross

AC, Taylor CL, Yaktine AL, DelValle HB. Dietary Reference Intakes

for Calcium and Vitamin D. In. Washington D.C.: Institute of

Medicine; 2011: 1132.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R8" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">8.

Holick&nbsp;MF.&nbsp;Vitamin D deficiency. N Engl J Med&nbsp;2007;

357:266-81; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/17634462" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">17634462</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1056/NEJMra070553" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1056/NEJMra070553</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R9" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">9.

Baeke&nbsp;F, Takiishi&nbsp;T, Korf&nbsp;H, Gysemans&nbsp;C,

Mathieu&nbsp;C.&nbsp;Vitamin D: modulator of the immune system.

Curr Opin Pharmacol&nbsp;2010; 10:482-96; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/20427238" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">20427238</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1016/j.coph.2010.04.001" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1016/j.coph.2010.04.001</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R10" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.

Bartley&nbsp;J.&nbsp;Vitamin D: emerging roles in infection and

immunity. Expert Rev Anti Infect Ther&nbsp;2010; 8:1359-69;

PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21133662" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21133662</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1586/eri.10.102" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1586/eri.10.102</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R11" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">11.

Jeurissen&nbsp;A, Van Etten&nbsp;E, Overbergh&nbsp;L, Wuyts&nbsp;G,

Heremans&nbsp;H, Matthys&nbsp;P, et al.&nbsp;1alpha,25-Dihydroxyvitamin

D3 modulates the murine antibody response to pneumococcal capsular

polysaccharide serotype 3 through IL-12. Eur J Immunol&nbsp;2005;

35:1841-8; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/15909307" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">15909307</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1002/eji.200425784" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1002/eji.200425784</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R12" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">12.

Hewison&nbsp;M.&nbsp;Antibacterial effects of vitamin D. Nat Rev

Endocrinol&nbsp;2011; 7:337-45; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21263449" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21263449</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1038/nrendo.2010.226" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1038/nrendo.2010.226</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R13" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">13.

Sadeghi&nbsp;K, Wessner&nbsp;B, Laggner&nbsp;U, Ploder&nbsp;M,

Tamandl&nbsp;D, Friedl&nbsp;J, et al.&nbsp;Vitamin D3

down-regulates monocyte TLR expression and triggers

hyporesponsiveness to pathogen-associated molecular patterns. Eur J

Immunol&nbsp;2006; 36:361-70; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/16402404" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">16402404</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1002/eji.200425995" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1002/eji.200425995</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R14" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">14.

Equils&nbsp;O, Naiki&nbsp;Y, Shapiro&nbsp;AM, Michelsen&nbsp;K,

Lu&nbsp;D, Adams&nbsp;J, et al.&nbsp;1,25-Dihydroxyvitamin D

inhibits lipopolysaccharide-induced immune activation in human

endothelial cells. Clin Exp Immunol&nbsp;2006; 143:58-64;

PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/16367934" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">16367934</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1111/j.1365-2249.2005.02961.x" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1111/j.1365-2249.2005.02961.x</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R15" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">15.

Horiuchi&nbsp;H, Nagata&nbsp;I, Komoriya&nbsp;K.&nbsp;Protective

effect of vitamin D3 analogues on endotoxin shock in mice. Agents

Actions&nbsp;1991; 33:343-8; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/1659158" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">1659158</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1007/BF01986584" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1007/BF01986584</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R16" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">16.

Asakura&nbsp;H, Aoshima&nbsp;K, Suga&nbsp;Y, Yamazaki&nbsp;M,

Morishita&nbsp;E, Saito&nbsp;M, et al.&nbsp;Beneficial effect of

the active form of vitamin D3 against LPS-induced DIC but not

against tissue-factor-induced DIC in rat models. Thromb

Haemost&nbsp;2001; 85:287-90; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/11246549" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">11246549</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R17" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">17.

M&oslash;ller&nbsp;S, Laigaard&nbsp;F, Olgaard&nbsp;K,

Hemmingsen&nbsp;C.&nbsp;Effect of 1,25-dihydroxy-vitamin D3 in

experimental sepsis. Int J Med Sci&nbsp;2007; 4:190-5;

PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/17657282" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">17657282</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.7150/ijms.4.190" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.7150/ijms.4.190</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R18" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">18.

Khoo&nbsp;AL, Chai&nbsp;LY, Koenen&nbsp;HJ, Kullberg&nbsp;BJ,

Joosten&nbsp;I, van der Ven&nbsp;AJ, et al.&nbsp;1,25-dihydroxyvitamin

D3 modulates cytokine production induced by Candida albicans:

impact of seasonal variation of immune responses. J Infect

Dis&nbsp;2011; 203:122-30; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21148505" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21148505</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1093/infdis/jiq008" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1093/infdis/jiq008</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R19" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">19.

Youssef&nbsp;DA, Miller&nbsp;CW, El-Abbassi&nbsp;AM, Cutchins&nbsp;DC,

Cutchins&nbsp;C, Grant&nbsp;WB, et al.&nbsp;Antimicrobial

implications of vitamin D. Dermatoendocrinol&nbsp;2011; 3:220-9;

PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/22259647" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">22259647</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.4161/derm.3.4.15027" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.4161/derm.3.4.15027</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R20" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">20.

Hansdottir&nbsp;S, Monick&nbsp;MM, Lovan&nbsp;N, Powers&nbsp;L,

Gerke&nbsp;A, Hunninghake&nbsp;GW.&nbsp;Vitamin D decreases

respiratory syncytial virus induction of NF-kappaB-linked

chemokines and cytokines in airway epithelium while maintaining the

antiviral state. J Immunol&nbsp;2010; 184:965-74; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/20008294" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">20008294</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.4049/jimmunol.0902840" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.4049/jimmunol.0902840</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R21" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21.

Nelson&nbsp;CD, Reinhardt&nbsp;TA, Beitz&nbsp;DC, Lippolis&nbsp;JD.&nbsp;In

vivo activation of the intracrine vitamin D pathway in innate

immune cells and mammary tissue during a bacterial infection. PLoS

One&nbsp;2010; 5:e15469; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21124742" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21124742</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1371/journal.pone.0015469" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1371/journal.pone.0015469</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R22" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">22.

Nijnik&nbsp;A, Hancock&nbsp;RE.&nbsp;The roles of cathelicidin

LL-37 in immune defences and novel clinical applications. Curr Opin

Hematol&nbsp;2009; 16:41-7; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/19068548" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">19068548</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1097/MOH.0b013e32831ac517" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1097/MOH.0b013e32831ac517</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R23" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">23.

Turner&nbsp;J, Cho&nbsp;Y, Dinh&nbsp;NN, Waring&nbsp;AJ,

Lehrer&nbsp;RI.&nbsp;Activities of LL-37, a cathelin-associated

antimicrobial peptide of human neutrophils. Antimicrob Agents

Chemother&nbsp;1998; 42:2206-14; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/9736536" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">9736536</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R24" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">24. Yim&nbsp;S,

Dhawan&nbsp;P, Ragunath&nbsp;C, Christakos&nbsp;S,

Diamond&nbsp;G.&nbsp;Induction of cathelicidin in normal and CF

bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J Cyst

Fibros&nbsp;2007; 6:403-10; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/17467345" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">17467345</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1016/j.jcf.2007.03.003" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1016/j.jcf.2007.03.003</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R25" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">25.

Hertting&nbsp;O, Holm&nbsp;A, L&uuml;thje&nbsp;P, Brauner&nbsp;H,

Dyrdak&nbsp;R, Jonasson&nbsp;AF, et al.&nbsp;Vitamin D induction of

the human antimicrobial Peptide cathelicidin in the urinary

bladder. PLoS One&nbsp;2010; 5:e15580; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21179490" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21179490</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1371/journal.pone.0015580" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1371/journal.pone.0015580</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R26" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">26.

Jeng&nbsp;L, Yamshchikov&nbsp;AV, Judd&nbsp;SE, Blumberg&nbsp;HM,

Martin&nbsp;GS, Ziegler&nbsp;TR, et al.&nbsp;Alterations in vitamin

D status and anti-microbial peptide levels in patients in the

intensive care unit with sepsis. J Transl Med&nbsp;2009; 7:28;

PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/19389235" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">19389235</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1186/1479-5876-7-28" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1186/1479-5876-7-28</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R27" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">27.

Hodgin&nbsp;KE, Moss&nbsp;M.&nbsp;The epidemiology of sepsis. Curr

Pharm Des&nbsp;2008; 14:1833-9; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/18691094" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">18691094</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.2174/138161208784980590" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.2174/138161208784980590</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R28" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">28.

Ginde&nbsp;AA, Mansbach&nbsp;JM, Camargo&nbsp;CA.&nbsp;Association

between serum 25-hydroxyvitamin D level and upper respiratory tract

infection in the Third National Health and Nutrition Examination

Survey. Arch Intern Med&nbsp;2009; 169:384-90; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/19237723" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">19237723</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1001/archinternmed.2008.560" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1001/archinternmed.2008.560</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R29" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">29.

Sabetta&nbsp;JR, DePetrillo&nbsp;P, Cipriani&nbsp;RJ, Smardin&nbsp;J,

Burns&nbsp;LA, Landry&nbsp;ML.&nbsp;Serum 25-hydroxyvitamin d and

the incidence of acute viral respiratory tract infections in

healthy adults. PLoS One&nbsp;2010; 5:e11088; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/20559424" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">20559424</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1371/journal.pone.0011088" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1371/journal.pone.0011088</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R30" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">30.

Laaksi&nbsp;I, Ruohola&nbsp;JP, Mattila&nbsp;V, Auvinen&nbsp;A,

Ylikomi&nbsp;T, Pihlajam&auml;ki&nbsp;H.&nbsp;Vitamin D

supplementation for the prevention of acute respiratory tract

infection: a randomized, double-blinded trial among young Finnish

men. J Infect Dis&nbsp;2010; 202:809-14; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/20632889" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">20632889</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1086/654881" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1086/654881</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R31" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">31.

Li-Ng&nbsp;M, Aloia&nbsp;JF, Pollack&nbsp;S, Cunha&nbsp;BA,

Mikhail&nbsp;M, Yeh&nbsp;J, et al.&nbsp;A randomized controlled

trial of vitamin D3 supplementation for the prevention of

symptomatic upper respiratory tract infections. Epidemiol

Infect&nbsp;2009; 137:1396-404; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/19296870" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">19296870</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1017/S0950268809002404" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1017/S0950268809002404</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R32" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">32.

Wayse&nbsp;V, Yousafzai&nbsp;A, Mogale&nbsp;K,

Filteau&nbsp;S.&nbsp;Association of subclinical vitamin D

deficiency with severe acute lower respiratory infection in Indian

children under 5 y. Eur J Clin Nutr&nbsp;2004; 58:563-7;

PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/15042122" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">15042122</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1038/sj.ejcn.1601845" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1038/sj.ejcn.1601845</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R33" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">33.

Karatekin&nbsp;G, Kaya&nbsp;A, Saliholu&nbsp;O, Balci&nbsp;H,

Nuholu&nbsp;A.&nbsp;Association of subclinical vitamin D

deficiency in newborns with acute lower respiratory infection and

their mothers. Eur J Clin Nutr&nbsp;2009; 63:473-7; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/18030309" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">18030309</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1038/sj.ejcn.1602960" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1038/sj.ejcn.1602960</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R34" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">34.

Roth&nbsp;DE, Shah&nbsp;R, Black&nbsp;RE, Baqui&nbsp;AH.&nbsp;Vitamin

D status and acute lower respiratory infection in early childhood

in Sylhet, Bangladesh. Acta Paediatr&nbsp;2010; 99:389-93;

PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/19900174" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">19900174</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1111/j.1651-2227.2009.01594.x" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1111/j.1651-2227.2009.01594.x</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R35" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">35.

Roth&nbsp;DE, Jones&nbsp;AB, Prosser&nbsp;C, Robinson&nbsp;JL,

Vohra&nbsp;S.&nbsp;Vitamin D status is not associated with the risk

of hospitalization for acute bronchiolitis in early childhood. Eur

J Clin Nutr&nbsp;2009; 63:297-9; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/17971825" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">17971825</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1038/sj.ejcn.1602946" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1038/sj.ejcn.1602946</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R36" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">36.

McNally&nbsp;JD, Leis&nbsp;K, Matheson&nbsp;LA, Karuananyake&nbsp;C,

Sankaran&nbsp;K, Rosenberg&nbsp;AM.&nbsp;Vitamin D deficiency in

young children with severe acute lower respiratory infection.

Pediatr Pulmonol&nbsp;2009; 44:981-8; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/19746437" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">19746437</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1002/ppul.21089" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1002/ppul.21089</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R37" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">37.

Manaseki-Holland&nbsp;S, Qader&nbsp;G, Isaq Masher&nbsp;M, Bruce&nbsp;J,

Zulf Mughal&nbsp;M, Chandramohan&nbsp;D, et al.&nbsp;Effects of

vitamin D supplementation to children diagnosed with pneumonia in

Kabul: a randomised controlled trial. Trop Med Int Health&nbsp;2010;

15:1148-55; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/20723187" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">20723187</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1111/j.1365-3156.2010.02578.x" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1111/j.1365-3156.2010.02578.x</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R38" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">38.

Urashima&nbsp;M, Segawa&nbsp;T, Okazaki&nbsp;M, Kurihara&nbsp;M,

Wada&nbsp;Y, Ida&nbsp;H.&nbsp;Randomized trial of vitamin D

supplementation to prevent seasonal influenza A in schoolchildren.

Am J Clin Nutr&nbsp;2010; 91:1255-60; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/20219962" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">20219962</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.3945/ajcn.2009.29094" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.3945/ajcn.2009.29094</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R39" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">39.

Martin&nbsp;GS, Mannino&nbsp;DM, Eaton&nbsp;S, Moss&nbsp;M.&nbsp;The

epidemiology of sepsis in the United States from 1979 through 2000.

N Engl J Med&nbsp;2003; 348:1546-54; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/12700374" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">12700374</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1056/NEJMoa022139" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1056/NEJMoa022139</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R40" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">40.

Matheson&nbsp;EM, Mainous&nbsp;AG, Hueston&nbsp;WJ, Diaz&nbsp;VA,

Everett&nbsp;CJ.&nbsp;Vitamin D and methicillin-resistant

Staphylococcus aureus nasal carriage. Scand J Infect Dis&nbsp;2010;

42:455-60; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/20210515" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">20210515</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.3109/00365541003602049" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.3109/00365541003602049</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R41" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">41.

Youssef&nbsp;D, Bailey&nbsp;B, El Abbassi&nbsp;A, Copeland&nbsp;R,

Adebonojo&nbsp;L, Manning&nbsp;T, et al.&nbsp;Healthcare costs of

Staphylococcus aureus and Clostridium difficile infections in

veterans: role of vitamin D deficiency. Epidemiol Infect&nbsp;2010;

138:1322-7; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/20056018" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">20056018</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1017/S0950268809991543" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1017/S0950268809991543</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R42" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">42. Lee&nbsp;P,

Eisman&nbsp;JA, Center&nbsp;JR.&nbsp;Vitamin D deficiency in

critically ill patients. N Engl J Med&nbsp;2009; 360:1912-4;

PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/19403914" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">19403914</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1056/NEJMc0809996" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1056/NEJMc0809996</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R43" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">43.

Pittas&nbsp;AG, Dawson-Hughes&nbsp;B.&nbsp;Vitamin D and diabetes.

J Steroid Biochem Mol Biol&nbsp;2010; 121:425-9; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/20304061" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">20304061</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1016/j.jsbmb.2010.03.042" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1016/j.jsbmb.2010.03.042</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R44" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">44. Van

den Berghe&nbsp;G, Van Roosbroeck&nbsp;D, Vanhove&nbsp;P,

Wouters&nbsp;PJ, De Pourcq&nbsp;L, Bouillon&nbsp;R.&nbsp;Bone

turnover in prolonged critical illness: effect of vitamin D. J Clin

Endocrinol Metab&nbsp;2003; 88:4623-32; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/14557432" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">14557432</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1210/jc.2003-030358" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1210/jc.2003-030358</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R45" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">45.

Lucidarme&nbsp;O, Messai&nbsp;E, Mazzoni&nbsp;T, Arcade&nbsp;M, du

Cheyron&nbsp;D.&nbsp;Incidence and risk factors of vitamin D

deficiency in critically ill patients: results from a prospective

observational study. Intensive Care Med&nbsp;2010; 36:1609-11;

PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/20373095" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">20373095</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1007/s00134-010-1875-8" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1007/s00134-010-1875-8</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R46" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">46.

McKinney&nbsp;JD, Bailey&nbsp;BA, Garrett&nbsp;LH, Peiris&nbsp;P,

Manning&nbsp;T, Peiris&nbsp;AN.&nbsp;Relationship between vitamin D

status and ICU outcomes in veterans. J Am Med Dir Assoc&nbsp;2011;

12:208-11; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21333923" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21333923</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1016/j.jamda.2010.04.004" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1016/j.jamda.2010.04.004</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R47" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">47.

Venkatram&nbsp;S, Chilimuri&nbsp;S, Adrish&nbsp;M, Salako&nbsp;A,

Patel&nbsp;M, Diaz-Fuentes&nbsp;G.&nbsp;Vitamin D deficiency is

associated with mortality in the medical intensive care unit. Crit

Care&nbsp;2011; 15:R292; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/22152332" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">22152332</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1186/cc10585" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1186/cc10585</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R48" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">48.

Flynn&nbsp;L, Zimmerman&nbsp;LH, McNorton&nbsp;K, Dolman&nbsp;M,

Tyburski&nbsp;J, Baylor&nbsp;A, et al.&nbsp;Effects of vitamin D

deficiency in critically ill surgical patients. Am J Surg&nbsp;2012;

203:379-82; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/22206852" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">22206852</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1016/j.amjsurg.2011.09.012" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1016/j.amjsurg.2011.09.012</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R49" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">49.

Braun&nbsp;A, Chang&nbsp;D, Mahadevappa&nbsp;K, Gibbons&nbsp;FK,

Liu&nbsp;Y, Giovannucci&nbsp;E, et al.&nbsp;Association of low

serum 25-hydroxyvitamin D levels and mortality in the critically

ill. Crit Care Med&nbsp;2011; 39:671-7; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21242800" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21242800</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1097/CCM.0b013e318206ccdf" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1097/CCM.0b013e318206ccdf</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R50" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">50.

Braun&nbsp;AB, Gibbons&nbsp;FK, Litonjua&nbsp;AA, Giovannucci&nbsp;E,

Christopher&nbsp;KB.&nbsp;Low serum 25-hydroxyvitamin D at critical

care initiation is associated with increased mortality. Crit Care

Med&nbsp;2012; 40:63-72; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21926604" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21926604</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1097/CCM.0b013e31822d74f3" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1097/CCM.0b013e31822d74f3</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R51" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">51.

Cecchi&nbsp;A, Bonizzoli&nbsp;M, Douar&nbsp;S, Mangini&nbsp;M,

Paladini&nbsp;S, Gazzini&nbsp;B, et al.&nbsp;Vitamin D deficiency

in septic patients at ICU admission is not a mortality predictor.

Minerva Anestesiol&nbsp;2011; 77:1184-9; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21720281" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21720281</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R52" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">52.

Ginde&nbsp;AA, Camargo&nbsp;CA, Shapiro&nbsp;NI.&nbsp;Vitamin D

insufficiency and sepsis severity in emergency department patients

with suspected infection. Acad Emerg Med&nbsp;2011; 18:551-4;

PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21518095" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21518095</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1111/j.1553-2712.2011.01047.x" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1111/j.1553-2712.2011.01047.x</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R53" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">53.

Krishnan&nbsp;A, Ochola&nbsp;J, Mundy&nbsp;J, Jones&nbsp;M,

Kruger&nbsp;P, Duncan&nbsp;E, et al.&nbsp;Acute fluid shifts

influence the assessment of serum vitamin D status in critically

ill patients. Crit Care&nbsp;2010; 14:R216; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21110839" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21110839</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1186/cc9341" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1186/cc9341</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R54" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">54.

Grant&nbsp;WB.&nbsp;Solar ultraviolet-B irradiance and vitamin D

may reduce the risk of septicemia. Dermatoendocrinol&nbsp;2009;

1:37-42; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/20046587" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">20046587</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.4161/derm.1.1.7250" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.4161/derm.1.1.7250</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R55" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">55.

Danai&nbsp;PA, Sinha&nbsp;S, Moss&nbsp;M, Haber&nbsp;MJ,

Martin&nbsp;GS.&nbsp;Seasonal variation in the epidemiology of

sepsis. Crit Care Med&nbsp;2007; 35:410-5; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/17167351" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">17167351</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1097/01.CCM.0000253405.17038.43" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1097/01.CCM.0000253405.17038.43</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R56" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">56.

Maxwell&nbsp;JD.&nbsp;Seasonal variation in vitamin D. Proc Nutr

Soc&nbsp;1994; 53:533-43; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/7886053" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">7886053</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1079/PNS19940063" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1079/PNS19940063</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R57" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">57.

Kimlin&nbsp;MG.&nbsp;Geographic location and vitamin D synthesis.

Mol Aspects Med&nbsp;2008; 29:453-61; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/18786559" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">18786559</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1016/j.mam.2008.08.005" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1016/j.mam.2008.08.005</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R58" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">58.

Kimlin&nbsp;MG, Olds&nbsp;WJ, Moore&nbsp;MR.&nbsp;Location and

vitamin D synthesis: is the hypothesis validated by geophysical

data?. J Photochem Photobiol B&nbsp;2007; 86:234-9; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/17142054" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">17142054</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1016/j.jphotobiol.2006.10.004" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1016/j.jphotobiol.2006.10.004</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R59" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">59.

Esper&nbsp;AM, Moss&nbsp;M, Lewis&nbsp;CA, Nisbet&nbsp;R,

Mannino&nbsp;DM, Martin&nbsp;GS.&nbsp;The role of infection and

comorbidity: Factors that influence disparities in sepsis. Crit

Care Med&nbsp;2006; 34:2576-82; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/16915108" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">16915108</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1097/01.CCM.0000239114.50519.0E" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1097/01.CCM.0000239114.50519.0E</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R60" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">60.

Mayr&nbsp;FB, Yende&nbsp;S, Linde-Zwirble&nbsp;WT, Peck-Palmer&nbsp;OM,

Barnato&nbsp;AE, Weissfeld&nbsp;LA, et al.&nbsp;Infection rate and

acute organ dysfunction risk as explanations for racial differences

in severe sepsis. JAMA&nbsp;2010; 303:2495-503; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/20571016" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">20571016</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1001/jama.2010.851" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1001/jama.2010.851</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R61" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">61.

Grant&nbsp;WB, Peiris&nbsp;AN.&nbsp;Possible role of serum

25-hydroxyvitamin D in black-white health disparities in the United

States. J Am Med Dir Assoc&nbsp;2010; 11:617-28; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21029996" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">21029996</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1016/j.jamda.2010.03.013" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1016/j.jamda.2010.03.013</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<BR>

</P>

<DIV ID="R62" DIR="LTR">

<P ALIGN=JUSTIFY STYLE="margin-bottom: 0in; border: none; padding: 0in; line-height: 0.19in; widows: 2; orphans: 2">

<FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">62.

Chen&nbsp;TC, Chimeh&nbsp;F, Lu&nbsp;Z, Mathieu&nbsp;J, Person&nbsp;KS,

Zhang&nbsp;A, et al.&nbsp;Factors that influence the cutaneous

synthesis and dietary sources of vitamin D. Arch Biochem

Biophys&nbsp;2007; 460:213-7; PMID:&nbsp;</FONT></FONT><A HREF="http://www.ncbi.nlm.nih.gov/pubmed/17254541" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">17254541</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">;

DOI:&nbsp;</FONT></FONT><A HREF="http://dx.doi.org/10.1016/j.abb.2006.12.017" TARGET="_blank"><FONT COLOR="#804000"><SPAN STYLE="text-decoration: none"><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">10.1016/j.abb.2006.12.017</FONT></FONT></SPAN></FONT></A><FONT FACE="inherit"><FONT SIZE=2 STYLE="font-size: 9pt">.</FONT></FONT></P>

</DIV>

</DIV>

<P STYLE="margin-bottom: 0in"><BR>

</P>

</BODY>

</HTML>